The page is the record's research on the issuer — no analyst, no rating, no view.

Nanologica AB (SE0005454873) — research page

SE · se-cm-kg/XSTO/SE0005454873 · as of 2026-11-06

Identity and listing

The issuer is Nanologica AB, listed on Nasdaq Stockholm under ticker SE0005454873, with ISIN SE0005454873 and LEI 54930017L41C7P87LP22. The security type, segment, sector and jurisdiction are not on the record. The issuer is listed, not halted.

fieldvaluesource · read date
nameNanologica ABsource · 2026-11-06
exchangeNasdaq Stockholmsource · 2026-11-06
tickerSE0005454873source · 2026-11-06
ISINSE0005454873source · 2026-11-06
LEI54930017L41C7P87LP22source · 2026-11-09
security typenot on the record
segmentnot on the record
sectornot on the record
jurisdictionnot on the record
statuslisted, not haltedsource · 2026-11-09

The disclosure read

The record holds 29 filings across 26 filing days in the twelve months to 2026-11-06. The median gap between filing days is 6 days. The latest filing is 4 days before the record date. The median cadence on Nasdaq Stockholm is 9.5 days across 398 issuers, and the median latency is 7.0 days. The sector median is not on the record. The latest filing is dated 2026-11-02 and is a Prospectus/Announcement of Prospectus.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer2964
exchange median: Nasdaq Stockholm (398 issuers)309.57
datetypecategoryfiling
2026-11-02Prospectus/Announcement of ProspectusProspectus/Announcement of ProspectusNANOLOGICA PUBLISHES INFORMATION DOCUMENT REGARDING RIGHTS ISSUE OF UNITS
2026-10-27Notice to general meetingNotice to general meetingNOTICE OF EXTRAORDINARY GENERAL MEETING OF NANOLOGICA AB (PUBL)
2026-10-23Inside informationInside informationNANOLOGICA RESOLVES ON A PARTIALLY GUARANTEED RIGHTS ISSUE OF UNITS OF APPX. SEK 110.5 MILLION WITH AN OVERSUBSCRIPTION OPTION OF AN ADDITIONAL SEK 10 MILLION
2026-10-23Changes board/management/auditorsChanges board/management/auditorsNANOLOGICA UPDATES STRATEGY AND APPOINTS NEW CEO TO DRIVE COMMERCIAL GROWTH AND PROFITABILITY
2026-08-31Half Year financial reportHalf Year financial reportInterim Report Q2 2026 Nanologica AB (publ)

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is not on the record, and neither is its location. Auditor changes are not on the record, because this register has no lifecycle type map yet.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, because this register has no lifecycle type map yet. The issuer is listed, not halted.

Orderability

The outcome is not determinable for this issuer. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.

rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

One research house is named on the issuer's investor-relations page: Redeye.

research houseanalystsource · read date
RedeyeFilip Einarssonissuer page · 2026-11-12

Open research

Three openly published research notes are on the record, all by Redeye: 2025-06-12, 2023-10-01 and 2023-08-01.

datepublishernotekind
2025-06-12RedeyeNanologica: US production evaluation orderindependent
2023-10-01RedeyeRedeye Research Report – Q3 2023 Untapped Potential Aheadindependent
2023-08-01RedeyeQ2 2023 – Estimates largely maintainedindependent

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record start date is not on the record.

Sources

10 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://firds.esma.europa.eu/firds/ (identity.exchange)
10.2
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.3
https://mcp.se-cm-kg.ai/events/XSTO/SE0005454873 (the disclosure lines)
10.4
https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
10.5
https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
10.6
https://nanologica.com/analysts-and-analyses/ (coverage)
10.7
https://nanologica.com/wp-content/uploads/2025/06/nanologica-us-production-evaluation-order-2025-06-12.pdf (open research)
10.8
https://nanologica.com/wp-content/uploads/2023/10/Redeye-Research-Report-Q3-2023-Untapped-Potential-Ahead.pdf (open research)
10.9
https://nanologica.com/wp-content/uploads/2023/08/Q2-2023-%E2%80%93-Estimates-largely-maintained.pdf (open research)
10.10
https://mcp.se-cm-kg.ai/record/XSTO/SE0005454873 (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0005454873"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:a437995507c6b7d3.